An engineered IL-2 reprogrammed for anti-tumor therapy using a semi-synthetic organism.
Nat Commun
; 12(1): 4785, 2021 08 09.
Article
in En
| MEDLINE
| ID: mdl-34373459
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Interleukin-2
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Nat Commun
Journal subject:
BIOLOGIA
/
CIENCIA
Year:
2021
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Reino Unido